DEA, Medical Evaluation and Research and Development

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

DEA

Medical Evaluation

Research and Development

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Cannabis Law Report

JANUARY 30, 2019

For nearly fifty years, the University of Mississippi has had the sole contract with the National Institute on Drug Abuse (NIDA) to grow cannabis for research purposes. Do you intend to support the expansion of marijuana manufacturers for scientific research? R ESPONSE: Yes. RESPONSE: I have not studied this issue closely.

Research and Development

Research and Development CBD DEA Law

Three Myths and Three Facts on the HUGE Marijuana Rescheduling Recommendation

Canna Law Blog

AUGUST 31, 2023

This all looks pretty good right now, but the Drug Enforcement Administration (DEA) and ultimately the Attorney General (AG) have final say on whether to schedule or reschedule marijuana following the HHS recommendation. In any case, the DEA Administrator reports to the AG (through the Deputy AG). The AG could then reschedule.

DEA

DEA Marijuana Banking Research and Development

Medical Cannabis Brief

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Three Myths and Three Facts on the HUGE Marijuana Rescheduling Recommendation

Stay Connected